annual cash & cash equivalents:
$288.45M-$5.35M(-1.82%)Summary
- As of today (May 29, 2025), ASTH annual cash & cash equivalents is $288.45 million, with the most recent change of -$5.35 million (-1.82%) on December 31, 2024.
- During the last 3 years, ASTH annual cash & cash equivalents has risen by +$55.36 million (+23.75%).
- ASTH annual cash & cash equivalents is now -1.82% below its all-time high of $293.81 million, reached on December 31, 2023.
Performance
ASTH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$258.52M-$29.94M(-10.38%)Summary
- As of today (May 29, 2025), ASTH quarterly cash & cash equivalents is $258.52 million, with the most recent change of -$29.94 million (-10.38%) on March 31, 2025.
- Over the past year, ASTH quarterly cash & cash equivalents has dropped by -$76.28 million (-22.78%).
- ASTH quarterly cash & cash equivalents is now -25.71% below its all-time high of $347.99 million, reached on September 30, 2024.
Performance
ASTH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ASTH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.8% | -22.8% |
| 3 y3 years | +23.8% | +8.7% |
| 5 y5 years | +179.5% | +219.6% |
ASTH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.8% | +23.8% | -25.7% | +40.5% |
| 5 y | 5-year | -1.8% | +179.5% | -25.7% | +219.6% |
| alltime | all time | -1.8% | >+9999.0% | -25.7% | >+9999.0% |
ASTH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $258.52M(-10.4%) |
| Dec 2024 | $288.45M(-1.8%) | $288.45M(-17.1%) |
| Sep 2024 | - | $347.99M(+7.0%) |
| Jun 2024 | - | $325.31M(-2.8%) |
| Mar 2024 | - | $334.80M(+14.0%) |
| Dec 2023 | $293.81M(+2.0%) | $293.81M(+7.3%) |
| Sep 2023 | - | $273.94M(-6.8%) |
| Jun 2023 | - | $293.92M(+7.0%) |
| Mar 2023 | - | $274.61M(-4.7%) |
| Dec 2022 | $288.03M(+23.6%) | - |
| Dec 2022 | - | $288.03M(+56.5%) |
| Sep 2022 | - | $184.02M(-21.4%) |
| Jun 2022 | - | $234.22M(-1.6%) |
| Mar 2022 | - | $237.94M(+2.1%) |
| Dec 2021 | $233.10M(+20.5%) | $233.10M(+13.8%) |
| Sep 2021 | - | $204.77M(+15.5%) |
| Jun 2021 | - | $177.29M(-13.9%) |
| Mar 2021 | - | $205.88M(+6.4%) |
| Dec 2020 | $193.47M(+87.5%) | $193.47M(+16.5%) |
| Sep 2020 | - | $166.08M(+8.9%) |
| Jun 2020 | - | $152.44M(+88.5%) |
| Mar 2020 | - | $80.89M(-21.6%) |
| Dec 2019 | $103.19M(-3.5%) | $103.19M(-55.2%) |
| Sep 2019 | - | $230.30M(+336.8%) |
| Jun 2019 | - | $52.73M(-43.3%) |
| Mar 2019 | - | $93.01M(-13.0%) |
| Dec 2018 | $106.89M(+7.2%) | $106.89M(-10.8%) |
| Sep 2018 | - | $119.78M(+18.4%) |
| Jun 2018 | - | $101.13M(-2.5%) |
| Mar 2018 | - | $103.73M(+243.4%) |
| Dec 2017 | $99.75M(+1051.3%) | - |
| Sep 2017 | - | $30.20M(-3.2%) |
| Jun 2017 | - | $31.21M(+260.2%) |
| Mar 2017 | $8.66M(-6.5%) | $8.66M(+117.2%) |
| Dec 2016 | - | $3.99M(+5.1%) |
| Sep 2016 | - | $3.79M(-41.7%) |
| Jun 2016 | - | $6.51M(-29.8%) |
| Mar 2016 | $9.27M(+84.9%) | $9.27M(+99.6%) |
| Dec 2015 | - | $4.64M(+18.3%) |
| Sep 2015 | - | $3.92M(+0.9%) |
| Jun 2015 | - | $3.89M(-22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | $5.01M(-26.6%) | $5.01M(-27.9%) |
| Dec 2014 | - | $6.95M(+76.0%) |
| Sep 2014 | - | $3.95M(-31.5%) |
| Jun 2014 | - | $5.76M(+297.0%) |
| Mar 2014 | $6.83M(+370.7%) | - |
| Jan 2014 | $1.45M(+23.3%) | $1.45M(+43.4%) |
| Oct 2013 | - | $1.01M(-19.2%) |
| Jul 2013 | - | $1.25M(-20.5%) |
| Apr 2013 | - | $1.58M(+33.9%) |
| Jan 2013 | $1.18M(+615.8%) | $1.18M(+134.9%) |
| Oct 2012 | - | $501.00K(+93.4%) |
| Jul 2012 | - | $259.10K(+33.6%) |
| Apr 2012 | - | $193.90K(+17.9%) |
| Jan 2012 | $164.40K(-58.6%) | $164.40K(-34.2%) |
| Oct 2011 | - | $249.70K(-27.2%) |
| Jul 2011 | - | $343.20K(+21.7%) |
| Apr 2011 | - | $281.90K(-29.0%) |
| Jan 2011 | $397.10K(-40.3%) | $397.10K(-20.8%) |
| Oct 2010 | - | $501.60K(-6.1%) |
| Jul 2010 | - | $534.30K(+5.9%) |
| Apr 2010 | - | $504.50K(-24.2%) |
| Jan 2010 | $665.70K(+690.6%) | $665.70K(-22.9%) |
| Oct 2009 | - | $863.40K(+851.9%) |
| Jul 2009 | - | $90.70K(+53.2%) |
| Apr 2009 | - | $59.20K(-29.7%) |
| Jan 2009 | $84.20K(>+9900.0%) | $84.20K(-43.1%) |
| Oct 2008 | - | $148.10K(+63.6%) |
| Jul 2008 | - | $90.50K(>+9900.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(-100.0%) |
| Mar 2005 | - | $300.00(+200.0%) |
| Dec 2004 | $100.00(-75.0%) | $100.00(0.0%) |
| Sep 2004 | - | $100.00(-50.0%) |
| Jun 2004 | - | $200.00(-33.3%) |
| Mar 2004 | - | $300.00 |
| Dec 2003 | $400.00 | - |
FAQ
- What is Astrana Health annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Astrana Health?
- What is Astrana Health annual cash & cash equivalents year-on-year change?
- What is Astrana Health quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Astrana Health?
- What is Astrana Health quarterly cash & cash equivalents year-on-year change?
What is Astrana Health annual cash & cash equivalents?
The current annual cash & cash equivalents of ASTH is $288.45M
What is the all time high annual cash & cash equivalents for Astrana Health?
Astrana Health all-time high annual cash & cash equivalents is $293.81M
What is Astrana Health annual cash & cash equivalents year-on-year change?
Over the past year, ASTH annual cash & cash equivalents has changed by -$5.35M (-1.82%)
What is Astrana Health quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ASTH is $258.52M
What is the all time high quarterly cash & cash equivalents for Astrana Health?
Astrana Health all-time high quarterly cash & cash equivalents is $347.99M
What is Astrana Health quarterly cash & cash equivalents year-on-year change?
Over the past year, ASTH quarterly cash & cash equivalents has changed by -$76.28M (-22.78%)